We have over 30 years of diverse experience in polymeric drug delivery systems, stable protein/peptide formulation design, combination product/device delivery, and polymeric biomaterials. Our efforts at Amgen and Ciba-Geigy (now Novartis) led to development of several product candidates useful for the biopharmaceutical, vision care, and agricultural areas. Two of these candidates became marketed products. One is a soft crosslinked polymeric hydrogel contact lens and the other is the long circulating PEGylated protein Neulasta, a multi-billion dollar a year product, which grew out of our site-specific modification know-how.
